Substantial Decrease in Vancomycin-Resistant

Aged COVID-19 Carrier State / microbiology Denmark / epidemiology Enterococcus faecium / drug effects Female Hospitalization Humans Male Pandemics Quarantine Streptococcal Infections / epidemiology Vancomycin Resistance / genetics Whole Genome Sequencing
SARS-CoV-2 VRE health care-associated infections infection control bundle strategies whole-genome sequencing

Journal

Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 8 9 2021
medline: 21 1 2022
entrez: 7 9 2021
Statut: ppublish

Résumé

Vancomycin-resistant

Identifiants

DOI: 10.1089/mdr.2021.0040 PMID: 34491861
pubmed: 34491861
doi: 10.1089/mdr.2021.0040
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

73-80

Auteurs

Katrine Lauridsen Gisselø (KL)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

Ingrid Maria Cecilia Rubin (IMC)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Department of Gastroenterology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
ORCID: 0000-0002-6158-2927

Maja Søndergaard Knudsen (MS)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

Michelle From-Hansen (M)

Infection Control, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark.

Marie Stangerup (M)

Infection Control, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark.

Christiane Pahl Kavalaris (CP)

Infection Control, Copenhagen University Hospital Bispebjerg, Copenhagen NV, Denmark.

Mette Pinholt (M)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

Sarah Mollerup (S)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

Henrik Westh (H)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Institute of Clinical Medicine, Copenhagen N, University of Copenhagen, Copenhagen N, Denmark.

Mette Damkjær Bartels (MD)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.

Andreas Munk Petersen (AM)

Department of Clinical Microbiology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Department of Gastroenterology, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Institute of Clinical Medicine, Copenhagen N, University of Copenhagen, Copenhagen N, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › État de porteur sain › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Régions géographiques › Europe › Pays nordiques et scandinaves › Danemark › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Enterococcus faecium › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Soins aux patients › Hospitalisation › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Contrôle des maladies transmissibles › Quarantaine › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › Infections à streptocoques › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Résistance à la vancomycine › Substantial Decrease in Vancomycin-Resistant
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Séquençage du génome entier › Substantial Decrease in Vancomycin-Resistant